Bookmark and Share

Last Minute: "The G7 must find strength and unity to overcome huge challenges - or its enemies will be strengthened - Sky News" Sun, 26 Jun 2022 00:43:22 GMT    "Russia-Ukraine war: what we know on day 123 of the invasion - The Guardian" Sun, 26 Jun 2022 02:14:00 GMT    "Rail strikes disrupt weekend plans across the south of England - BBC" Sat, 25 Jun 2022 12:04:51 GMT    "Pictured: Norway terror suspect charged with killing two people at gay bar in Oslo - The Independent" Sat, 25 Jun 2022 18:37:22 GMT    "Conservatives? alarm grows over threat of tactical voting in safe seats - The Guardian" Sun, 26 Jun 2022 06:00:00 GMT    "Britain is being hit by a new wave of Covid ? so what do we do now? - The Guardian" Sat, 25 Jun 2022 16:09:00 GMT   "Boris Johnson's latest plan to rebuild Britain is crumbling already - The Times" Sat, 25 Jun 2022 17:00:00 GMT    "Boris Johnson seeks to stay in power until the mid-2030s - Reuters" Sat, 25 Jun 2022 23:07:00 GMT    "My sister Ghislaine's faith in US justice betrayed her - The Telegraph" Sat, 25 Jun 2022 20:00:00 GMT    "World leaders condemn US abortion ruling as ?backwards step? - The Guardian" Sat, 25 Jun 2022 09:43:00 GMT      For more news, click here.

Remember me? 

PS: The quotes after 2018-12-04 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Pfizer Static Chart

Fall of
--0.85 (+0.98%) Pfizer - [Ticker: PFE]Chart Pfizer  News Pfizer  Download Historical Prices for Metastock Pfizer and Others  Technical Analysis Pfizer  
Last Trade45.14Last Trade Time2018-12-04 - 00:00:00
Variation--0.85 (+0.98%)Open46.23
Volume26,062,310Average Volume (3m)0
YieldBid / Ask35.33 x 5,700 - 35.34 x 8,100
Former Close45.9952 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about Pfizer [PFE]:   (ordered by relevance)
  1. BioNTech/Pfizer say Omicron-targeting boosters elicit strong immune response  Financial Times
  2. Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron  Pfizer
  3. Pfizer says tweaked COVID-19 shots boost omicron protection  The Independent
  4. Pfizer and BioNTech say updated Covid-19 boosters show increased immune response against Omicron variant  CNN
  5. Pfizer says its Omicron-containing boosters outperform current vaccine  STAT
Pfizer's Russian profit donation plan running smoothly, CEO says  FiercePharma How To Buy Pfizer (PFE) Stock ? Forbes Advisor Canada  Forbes Valneva and Pfizer Announce Closing of Equity Investment  Pfizer Pfizer CEO: What's next for vaccines, tech and the pandemic  World Economic Forum Hedeker Wealth LLC Sells 39847 Shares of Pfizer Inc. (NYSE:PFE)  Defense World Pfizer is first big pharma to tap Truveta's real-world data platform -  pharmaphorum CVS Health returns BMS, Pfizer's Eliquis to formulary  FiercePharma Freedom of Information request on the ingredients in the Pfizer COVID-19 vaccination (FOI 22/403)  GOV.UK BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody's  FiercePharma CHoMP: Westphal's Dem gobbles up $70M in Pfizer-backed round to fund macrophage cancer R&D  FierceBiotech Pfizer to exit GSK consumer health joint venture after London listing  Financial Times Young Men's Myocarditis Risk 5 Times Higher With Moderna vs Pfizer Vax  Medpage Today Pfizer and BioNTech Provide Update on Rolling Submission to European Medicines Agency for a Potential Variant-Adapted Vaccine  Pfizer Pfizer Completes Acquisition of ReViral  Pfizer Pfizer sets sights on elimination of blinding disease trachoma by 2030 - Health - Life & Style  Ahram Online Pfizer Invests $120 Million in Paxlovid Production  Investopedia 3 reasons why Pfizer (NYSE:PFE) might be a great buy  Motley Fool UK Pfizer Reports Additional Data on PAXLOVID? Supporting Upcoming New Drug Application Submission to US FDA  Pfizer Enanta lawsuit claims Pfizer's Paxlovid infringes its patent -  pharmaphorum Why Pfizer, BioNTech, and Moderna Stocks Are Sinking Today  The Motley Fool Pfizer-BioNTech shot for children under 5 safe and effective, FDA staff says  The Washington Post Pfizer Covid Vaccine Protects Against Omicron Sublineages BA.4 and BA.5: Study  Bloomberg Pfizer shoots back at Alnylam's claims in high-stakes COVID-19 vaccine patent case  FiercePharma Why Moderna and Pfizer Lagged the Market Today  The Motley Fool Health Product Market Outlook 2022 And Growth By Top KeyPlayers ? Pfizer, Nestle, Arbonne, GSK ? Designer Women  Designer Women Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know  Nasdaq Pfizer seeks authorization of coronavirus shot for children under 5  The Washington Post Pfizer Stock: The Pain Might Not Be Over (NYSE:PFE)  Seeking Alpha Freedom of Information request on temporary authorisations of the Pfizer/BioNTech, Oxford/AstraZeneca and Moderna vaccines which were done through an expedited rolling review (FOI 21-1228)  GOV.UK Pfizer Presents First Data from Planned Interim Analysis of Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab Under Investigation for Relapsed/Refractory Multiple Myeloma  Pfizer Pfizer and BioNTech Announced Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Respons  Benzinga Pfizer's vaccine raked in $37 billion in 2021 - nearly doubling the revenue of every other drug  Daily Mail Pfizer Inc. (NYSE:PFE) Receives Average Rating of "Moderate Buy" from Analysts  MarketBeat Pfizer Inc. (NYSE:PFE) Announces Quarterly Dividend of $0.40  MarketBeat GSK Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck  Investor's Business Daily Pfizer Inc. (PFE) CEO Albert Bourla Presents at the Bernstein 38th Annual Strategic Decisions Conference (Transcript)  Seeking Alpha Diflorasone Market Research With Sanofi, Pfizer, Novartis, Sun Pharma, Dérmico Farm | To reach good valuation as discussed in a new report ? Indian Defence News  Indian Defence News Pfizer Inc. (NYSE:PFE) Short Interest Up 33.9% in May  MarketBeat Axis Bank, JK Cement, PFizer among 171 BSE stocks to hit new 52-week lows; Kohinoor Foods at new high  The Financial Express Pfizer to offer all its drugs not-for-profit to 45 lower-income countries  The Guardian Investing in Pfizer Stock (PFE)  Investopedia Veterinary Diagnostic Market Outlook 2022 And Growth By Top KeyPlayers ? Pfizer, Thermo Fisher Scientific, Henry Schein, Virbac ? Designer Women  Designer Women Pfizer to buy biotech group Biohaven for $11.6bn  Financial Times Pfizer accused of pandemic profiteering as profits double  The Guardian Will Pfizer Stock Continue To Rise?  Forbes Pfizer Completes Acquisition of Arena Pharmaceuticals  Pfizer What's Next For Pfizer Stock After A 10% Fall In A Month?  Forbes Pfizer Updates Company Position in Russia  Pfizer Pfizer to Acquire Arena Pharmaceuticals  Pfizer The inside story of the Pfizer vaccine: 'a once-in-an-epoch windfall'  Financial Times Why Pfizer Stock Climbed Today  The Motley Fool Moderna and Pfizer urged to share vaccine technology with developing world  Financial Times Agreement with BioNTech-Pfizer to adapt delivery schedules  European Commission Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose  Pfizer Why Pfizer Stock Rose Today While the Market Tanked  The Motley Fool Is it Still Worthy to Invest in Pfizer (PFE)?  Yahoo Finance Why Pfizer Has a Wide Moat  Morningstar Pfizer warns of 'constant waves' of Covid as complacency grows  Financial Times Pfizer Announces 2022 Shareholder Meeting Preliminary Results  Pfizer Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission  Pfizer Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases  Pfizer Pfizer Is Under Pressure Today, Here Is Why  Yahoo Finance Pfizer and Moderna created life-saving vaccines. So why are their stocks crumbling?  CNN Pfizer and BioNTech Receive Positive CHMP Opinion for COVID-19 Vaccine Booster in Adolescents 12 through 17 Years of Age in the European Union  Pfizer Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age  Pfizer Can the momentum continue for Pfizer (NYQ:PFE)?  Yahoo Finance UK The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know  World Health Organization Pfizer and BioNTech Submit for US Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults  Pfizer Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference  Pfizer Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age  Pfizer Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From US FDA  Pfizer Pfizer Announces New Chief Development Officer  Pfizer Pfizer keeps 2022 COVID-19 vaccine, pill sales outlook unchanged  Al Jazeera English Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates  Pfizer Manufacturing Sites: Made in the USA  Pfizer Why Pfizer Stock Rose 10.3% in March  The Motley Fool Pfizer and BioNTech Granted US Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age  Pfizer Pfizer strikes deal to allow generic versions of its Covid pill for world?s poor  The Guardian Pfizer says three vaccine doses offer protection against Omicron  Financial Times Pfizer Invests $68.5 Million in New State-of-the-Art Facility in Durham, North Carolina to Further Advance Gene Therapy Capabilities  Pfizer Pfizer & Moderna Investors Run for the Exits  The Desert Review Pfizer Declares Second-Quarter 2022 Dividend  Pfizer Pfizer and BioNTech Submit Application for US Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age  Pfizer This Insider Has Just Sold Shares In Pfizer Inc. (NYSE:PFE)  Simply Wall St WHO urges Pfizer to make Covid antiviral drug pricing more transparent  Financial Times Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential  Pfizer Pfizer raises 2021 sales forecast for Covid vaccine to $36bn  Financial Times Pfizer and BioNTech Provide Update on Ongoing Studies of COVID-19 Vaccine  Pfizer Pfizer and BioNTech team up to develop mRNA-based shingles vaccine  Financial Times Pfizer Stock: How Pfizer's Nearly $7 Billion Takeover Of Arena Just Paid Off  Investor's Business Daily Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding  The Motley Fool Pfizer, BioNTech and Moderna making $1000 profit every second while world's poorest countries remain largely unvaccinated - World  ReliefWeb Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate  Pfizer Here's Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month  Forbes Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVID? for Post-Exposure Prophylactic Use  Pfizer Pfizer Stock: Vaccine Has Provided A Long-Term Boost (NYSE:PFE)  Seeking Alpha Pfizer (PFE) Paxlovid Withheld From Researchers Studying Drug Combinations  Bloomberg Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28  Pfizer Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death  Pfizer
For more news about Pfizer click here:
Pfizer News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources